Clinical Trial Update: Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pioglitazone versus rosiglitazone in adults with Type 2 diabetes mellitus and dyslipidemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Avandia (rosiglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED